Beta defensin 4A (DRFB4) is a membrane-active cationic peptide that functions in inflammation and innate immune responses. There are at least 30 and beta-defensins, which differ from ?-defensins by their three intermolecular disulfide linkages. The proteins of the defensin family are highly similar. DEFPB4 has broad-spectrum antibacterial activity and may play a crucial role in innate epithelial protection. They're highly activated in the skin and tonsils, although they are also expressed to a lesser extent in the trachea, uterus, kidney, thymus, adenoid, pharynx, and tongue. The salivary gland, bone marrow, colon, stomach, polyp and larynx all have low levels of beta-defensin 4A expression. DRFB4 has no expression in the small intestine. Alpha-Defensin 4A/DEFB4A Recombinant Protein is a highly pure recombinant protein developed by Assay Genie for use in a range of applications.
Alpha-Defensin 4A/DEFB4A Recombinant Protein (RPES3528)
Recombinant Human beta-Defensin 4A is produced by our E.coli expression system and the target gene encoding Gly24-Pro64 is expressed.
> 95 % as determined by reducing SDS-PAGE.
AP Mol Mass:
Lyophilized from a 0.2 µm filtered solution of 20mM PB, 130mM NaCl, pH 7.4.
This product is provided as lyophilized powder which is shipped with ice packs.
Stability and Storage:
Lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.